Monday, June 13, 2016 10:16:57 PM
Tweet Share E-mail
Get Alerts
TEVA Hot Sheet
Price: $53.22 +0.40%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.4%
EPS Growth %: -11.8%
Trade TEVA Now!
Join SI Premium – FREE
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Teva Pharmaceutical Industries, Ltd. (NYSE: TEVA) announced today that it will voluntarily suspend sales, marketing and distribution of ZECUITY® (sumatriptan iontophoretic transdermal system). Teva has received post-marketing reports of application site reactions described as burns and scars in patients treated with ZECUITY, and is working in full cooperation with the U. S. Food and Drug Administration (FDA) to better understand these adverse events. In addition to this voluntary suspension, Teva has initiated a pharmacy-level recall of the product.
“At Teva, the wellbeing of people using our products is always the first priority. Given our deep commitment to patient safety, we will engage in a voluntary suspension of marketing while we continue our investigation into the root cause of these adverse skin reactions,” said Rob Koremans, M.D., President and Chief Executive Officer of Global Specialty Medicines at Teva. “We will continue to work closely with the FDA to resolve any remaining questions.”
Patients are advised to discontinue the use of ZECUITY and discuss alternative treatment options with their physicians. Teva has issued a Dear Health Care Provider Letter to alert the prescribing
Recent PATH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 10:16:28 PM
- UiPath State of the Automation Professional Report Highlights 2024 as the Year of AI Integration • Business Wire • 09/16/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:24:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 08:17:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 08:20:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/06/2024 09:13:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 08:14:27 PM
- Broadcom Down 10% Post-Earnings, UiPath Up 8%; Qualcomm Eyes Intel Assets; Salesforce Acquires Own Company • IH Market News • 09/06/2024 11:59:00 AM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 09/05/2024 11:19:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:17:42 PM
- UiPath Reports Second Quarter Fiscal 2025 Financial Results • Business Wire • 09/05/2024 08:10:00 PM
- UiPath Chief Financial Officer Ashim Gupta Takes on Expanded Role as Chief Operating Officer • Business Wire • 09/05/2024 08:10:00 PM
- UiPath Appoints S. Somasegar to its Board of Directors • Business Wire • 09/05/2024 08:10:00 PM
- U.S. Index Futures Steady Amid Labor Data Anticipation; Oil Prices Rise • IH Market News • 09/05/2024 10:13:05 AM
- UiPath Unveils Partner Sponsors for FORWARD, the Largest Global Event for Automation and AI Practitioners • Business Wire • 09/04/2024 02:30:00 PM
- UiPath to Participate in the Piper Sandler Growth Frontiers Conference • Business Wire • 09/03/2024 08:10:00 PM
- UiPath Named a Leader in Everest Group Digital Interaction Intelligence Products PEAK Matrix® Assessment 2024 • Business Wire • 08/26/2024 12:33:00 PM
- UiPath, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 19, 2024 to Discuss Your Rights - PATH • PR Newswire (US) • 08/19/2024 09:45:00 AM
- UiPath, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 19, 2024 to Discuss Your Rights - PATH • PR Newswire (US) • 08/15/2024 09:45:00 AM
- UiPath Recognized as a Leader in the 2024 Gartner Magic Quadrant for Robotic Process Automation • Business Wire • 08/12/2024 03:56:00 PM
- Lost Money on UiPath, Inc.(PATH)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 08/12/2024 09:30:00 AM
- UiPath Announces Second Quarter Fiscal 2025 Financial Results Conference Call • Business Wire • 08/08/2024 08:10:00 PM
- The Gross Law Firm Reminds UiPath Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 19, 2024 - PATH • PR Newswire (US) • 08/08/2024 09:45:00 AM
- UiPath Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PATH • PR Newswire (US) • 08/06/2024 02:00:00 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM